469 items

NEI-Funded Device for People with RP Gets FDA Approval

February 18, 2013

On February 14, 2013, the U.S. Food and Drug Administration approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).

NIH study suggests immune system could play a central role in AMD

November 27, 2012

Changes in how genes in the immune system function may result in age-related macular degeneration (AMD), the leading cause of visual impairment in older adults, based on preliminary research conducted by National Institutes of Health (NIH) investigators.

United States and United Kingdom Collaborate on Ocular Immunology

June 5, 2012

The NEI, part of the National Institutes of Health (NIH), has become the first U.S. government agency to develop a formal collaborative research and training agreement with the United Kingdom’s National Health Service (NHS).

Avastin and Lucentis are equivalent in treating age-related macular degeneration

April 30, 2012

At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD).

National Institutes of Health releases data from largest pediatric eye study

August 19, 2011

Study estimates prevalence of vision disorders among preschool children in three ethnic groups, identifies risk factors
NIH National Eye Institute logo

NIH study shows two treatments for uveitis equally effective

August 17, 2011

Treating patients with severe cases of uveitis, the fifth leading cause of vision loss in the United States, either locally with eye implants or systemically with anti-inflammatory medications improved vision similarly over two years.

NIH study finds Avastin and Lucentis are equally effective in treating age-related macular degeneration

April 28, 2011

Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration (AMD).

LASIK Quality of Life Collaboration Project

March 28, 2011

In October 2009, the FDA, the National Eye Institute, and the Department of Defense launched the LASIK Quality of Life Collaboration Project.

NIH adds first images to major research database

November 22, 2010

More than 72,000 clinical photographs illustrate age-related eye disease progression

ACCORD Eye Study Finds Two Therapies Slow Diabetic Eye Disease Progression

June 29, 2010

In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.